Osteoarthritis Therapy: Nanocrystal–Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment (Small 8/2018)
Source abstract
Abstract
In article number 1703108, Eric Allémann and co-workers formulate a drug delivery system based on nanocrystal-polymer particles. Nanocrystals of drug are embedded in biodegradable microparticles to provide a long-term, intra-articular osteoarthritis therapy. This treatment is efficient in reducing the frequency of injections, and may fulfill an unmet medical need; the reconstitution of the cartilage. This approach shows promise as a safe drug delivery system to locally treat diseases over extended periods of time with a high drug loading.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Neurological Disorders and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmaceutical Sciences University of Geneva University of Lausanne CH‐1211 Geneva 4 Switzerland
Department of Clinical Science Idorsia Pharmaceuticals Ltd. CH‐4123 Allschwil Switzerland
Division of Rheumatology Department of Internal Medicine Specialties University Hospital and Department of Pathology and Immunology School of Medicine University of Geneva CH‐1211 Geneva 4 Switzerland
References
Reference metadata was not supplied for this record.